Rockwell Medical (NASDAQ:RMTI) Rating Increased to Buy at StockNews.com

StockNews.com upgraded shares of Rockwell Medical (NASDAQ:RMTI) from a hold rating to a buy rating in a research report sent to investors on Thursday morning.

Several other research firms have also recently weighed in on RMTI. RODMAN&RENSHAW raised Rockwell Medical to a “strong-buy” rating in a report on Thursday, November 14th. HC Wainwright reduced their price objective on Rockwell Medical from $9.00 to $7.00 and set a “buy” rating for the company in a research report on Monday, November 25th. Finally, Rodman & Renshaw began coverage on Rockwell Medical in a research report on Thursday, November 14th. They issued a “buy” rating and a $5.00 target price on the stock.

Rockwell Medical Stock Down 1.4 %

Shares of Rockwell Medical stock opened at $2.04 on Thursday. Rockwell Medical has a twelve month low of $1.16 and a twelve month high of $5.15. The company has a quick ratio of 2.00, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. The company’s 50 day moving average is $3.03 and its 200 day moving average is $2.69. The company has a market cap of $65.93 million, a price-to-earnings ratio of -40.80 and a beta of 1.38.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in RMTI. Barclays PLC bought a new stake in shares of Rockwell Medical during the 3rd quarter valued at $90,000. XTX Topco Ltd raised its holdings in Rockwell Medical by 45.7% in the 3rd quarter. XTX Topco Ltd now owns 28,455 shares of the company’s stock worth $113,000 after purchasing an additional 8,922 shares during the period. Jane Street Group LLC bought a new position in Rockwell Medical in the 3rd quarter worth $534,000. State Street Corp lifted its position in Rockwell Medical by 21.5% during the third quarter. State Street Corp now owns 95,004 shares of the company’s stock valued at $377,000 after purchasing an additional 16,800 shares in the last quarter. Finally, HighTower Advisors LLC grew its holdings in Rockwell Medical by 75.6% during the third quarter. HighTower Advisors LLC now owns 57,413 shares of the company’s stock valued at $228,000 after purchasing an additional 24,715 shares during the period. 23.31% of the stock is currently owned by institutional investors.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.